Work

Inactivation of VEGFR2 using CRISPR/Cas9 provides superior inhibition to the anti-VEGF drugs

Year: 2016

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Xionggao Huang, Gaoen Ma, Yewlin E. Chee, Shizuo Mukai, Patricia A. D’Amore, Hetian Lei

Institution: Massachusetts Eye and Ear Infirmary

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W2568545878

FWCI:

Cites:

Cited by:

Related to: 10